EMMAUS LIFE SCIENCES, INC. Chart calendar Emmaus Life Sciences, Inc.
a36f18d8ffea4d6cdcac4030.91JZ96MOeKwTtqse9gKx62Umj1qSR9ozcOMXBKEyhJs.zzwOnOJUIMdg-OdRjlrDrR91-G_HHo1lALxBPdZ_wayCEwGy03YTzWrSmw~6e990861c6628c2ec50607961fae710a
Upcoming events on Emmaus Life Sciences, Inc.
Past events on Emmaus Life Sciences, Inc.
| 09/05/2024 | Q1 2024 Earnings Release (Projected) |
| 14/11/2023 14:30 | Q3 2023 Earnings Release |
| 14/08/2023 20:54 | Q2 2023 Earnings Release |
| 15/05/2023 14:30 | Q1 2023 Earnings Release |
| 31/03/2023 21:15 | Q4 2022 Earnings Release |
| 08/12/2022 22:00 | Annual General Meeting |
| 14/11/2022 23:17 | Q3 2022 Earnings Release |
| 15/08/2022 21:30 | Interim 2022 Earnings Release |
| 23/06/2022 17:30 | OTC Markets Group Zacks Virtual Life Sciences Investor Conference |
| 24/05/2022 12:00 | H.C. Wainwright Global Life Sciences Investment Conference |
| 13/05/2022 13:23 | Q1 2022 Earnings Release |
| 03/05/2022 20:30 | Interim Investor Summit |
| 02/04/2022 | Meeting of the British Society for Haematology - E-Poster No.: BSH22- EP78 |
| 31/03/2022 22:24 | FY 2021 Earnings Release |
| 10/01/2022 12:00 | H.C. Wainwright BioConnect Conference |
| 16/12/2021 17:30 | OTC Markets Life Sciences Investor Forum |
| 13/12/2021 23:00 | American Society of Hematology Virtual Meeting and Exposition |
| 22/11/2021 | Annual General Meeting |
| 16/11/2021 19:00 | Investor Meeting |
| 12/11/2021 13:23 | Q3 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 20,6 23,0 -10.39% | 18,4 18,6 -1.18% |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -6,59 -5,40 -21.94% |
|
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
|
Net income Million USD | Released Forecast Spread | 1,10 | 0,00 0,00 - | 0,00 0,00 - |
|
EPS USD | Released Forecast Spread | 0,02 | 0,00 0,00 - | 0,00 0,00 - |
| Announcement Date | 04/05/21 | 31/03/22 | 31/03/23 |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,02 6,63 -54.46% | 3,23 6,00 -46.1% | 4,29 6,00 -28.55% | 4,94 6,00 -17.68% | 5,93 7,00 -15.29% | 6,75 5,00 35.06% |
|
EBIT Million USD | Released Forecast Spread | -4,97 2,25 -320.96% | |||||
| Announcement Date | 31/03/22 | 13/05/22 | 15/08/22 | 14/11/22 | 31/03/23 | 15/05/23 |
More events
Past sector events for Emmaus Life Sciences, Inc.
| 10/05/2024 12:00 | HUMACYTE, INC.: Q1 2024 Earnings Release |
| 09/05/2024 | NOVAVAX, INC.: Q1 2024 Earnings Release |
| 09/05/2024 | TAKARA BIO INC.: Q4 2023 Earnings Release |
| 09/05/2024 | CHABIOTECH CO.,LTD.: Q1 2024 Earnings Release (Projected) |
| 09/05/2024 21:10 | GYRE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:05 | ARS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:05 | HILLEVAX, INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:05 | BIOHAVEN LTD.: Q1 2024 Earnings Release |
| 09/05/2024 21:05 | OMNIAB, INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:05 | 4D MOLECULAR THERAPEUTICS, INC.: Q1 2024 Earnings Release |
